Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China · Delayed Price · Currency is CNY 22.83
+0.06 (0.26%)
Jul 17, 2025, 2:45 PM CST
SHA:600285 Revenue
Henan Lingrui Pharmaceutical had revenue of 1.02B CNY in the quarter ending March 31, 2025, with 12.29% growth. This brings the company's revenue in the last twelve months to 3.61B, up 5.26% year-over-year. In the year 2024, Henan Lingrui Pharmaceutical had annual revenue of 3.50B with 5.72% growth.
Revenue (ttm)
3.61B
Revenue Growth
+5.26%
P/S Ratio
3.56
Revenue / Employee
1.48M
Employees
2,435
Market Cap
12.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.50B | 189.36M | 5.72% |
| Dec 31, 2023 | 3.31B | 309.61M | 10.31% |
| Dec 31, 2022 | 3.00B | 308.35M | 11.45% |
| Dec 31, 2021 | 2.69B | 361.93M | 15.52% |
| Dec 31, 2020 | 2.33B | 174.53M | 8.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |